SBIO

ALPS Medical Breakthroughs ETF

Up$41.39
+$0.79
(+1.95%)
As of 1:00:00 AM EDT | 12/06/19  |  Market Closed

SBIO Trading Data

Open

$40.86

Low Price

$40.82

High Price

$41.41

Previous Last Price

$40.6

Bid Size

$0 X 0

Ask Size

$0 X 0

SBIO Portfolio Data

AUM

$204,650,000

Shares

5,000

PE Ratio

0

Price / Book Ratio

3.52

Expense Ratio

0.5

Net Asset Value

$40.93

Volume

Volume

48,000

Avg. Volume (YDT)

36,723

Dollar Volume

$0

Weekly Avg. Volume

44,400

Monthly Avg. Volume

37,205

Quarterly Avg. Volume

32,903

SBIO Fund Description

The ALPS Medical Breakthroughs ETF invests in the public equity markets of the United States. It invests in the stocks of companies operating in the biotechnology and pharmaceutical sectors. The fund invests in stocks of mid cap and small cap companies with a market capitalization of no less than $200 million and no more than $5 billion. It seeks to replicate the performance of the Poliwogg Medical Breakthroughs Index, by investing in the stocks of companies as per their weightings in the index.

SBIO Chart

SBIO Summary

Fund Family

ALPS Holdings

Tracks This Index

ALPS Medical Breakthroughs ETF

Inception Date

2015-01-05

Asset Class

Portfolio-Multi Asset

Asset Class Size

Healthcare

SBIO Classification

Region (General)

Global

Region (Specific)

Sector

Health Care

Equity Index

Leveraged Family

SBIO Holdings

Top 10 Holdings

ACADIA Pharmaceuticals Inc. (ACAD)
5.26%
Allakos Inc. (ALLK)
4.44%
United Therapeutics Corp. (UTHR)
4.3%
MorphoSys AG (MOR)
3.86%
Immunomedics Inc. (IMMU)
3.76%
Mirati Therapeutics Inc. (MRTX)
3.61%
Global Blood Therapeutics Inc. (GBT)
3.55%
FibroGen Inc. (FGEN)
3.52%
Alkermes PLC (ALKS)
3.48%
Halozyme Therapeutics Inc. (HALO)
2.95%

Total SBIO Holdings

Total Holdings: 79

ACADIA Pharmaceuticals Inc. (ACAD)
5.26%
Allakos Inc. (ALLK)
4.44%
United Therapeutics Corp. (UTHR)
4.3%
MorphoSys AG (MOR)
3.86%
Immunomedics Inc. (IMMU)
3.76%
Mirati Therapeutics Inc. (MRTX)
3.61%
Global Blood Therapeutics Inc. (GBT)
3.55%
FibroGen Inc. (FGEN)
3.52%
Alkermes PLC (ALKS)
3.48%
Halozyme Therapeutics Inc. (HALO)
2.95%
Emergent BioSolutions Inc. (EBS)
2.78%
PTC Therapeutics Inc. (PTCT)
2.71%
Acceleron Pharma Inc. (XLRN)
2.47%
Arena Pharmaceuticals Inc. (ARNA)
2.45%
Deciphera Pharmaceuticals Inc. (DCPH)
2.44%
uniQure NV (QURE)
2.34%
Ra Pharmaceuticals Inc. (RARX)
2.32%
Agios Pharmaceuticals Inc. (AGIO)
2.31%
Ligand Pharmaceuticals Inc. (LGND)
2.21%
Eidos Therapeutics Inc. (EIDX)
2.14%
Akcea Therapeutics Inc. (AKCA)
1.84%
Apellis Pharmaceuticals Inc. (APLS)
1.8%
Gossamer Bio Inc. (GOSS)
1.73%
Madrigal Pharmaceuticals Inc. (MDGL)
1.69%
Dicerna Pharmaceuticals Inc. (DRNA)
1.62%
Epizyme Inc. (EPZM)
1.57%
Enanta Pharmaceuticals Inc. (ENTA)
1.26%
Cara Therapeutics Inc. (CARA)
1.18%
Constellation Pharmaceuticals Inc. (CNST)
1.08%
Orchard Therapeutics PLC (ORTX)
1.04%
ArQule Inc. (ARQL)
1.04%
Y-mAbs Therapeutics Inc. (YMAB)
1.03%
Krystal Biotech Inc. (KRYS)
0.99%
Fate Therapeutics Inc. (FATE)
0.99%
G1 Therapeutics Inc. (GTHX)
0.93%
Achillion Pharmaceuticals Inc. (ACHN)
0.91%
Vericel Corp. (VCEL)
0.86%
Anika Therapeutics Inc. (ANIK)
0.84%
Rhythm Pharmaceuticals Inc. (RYTM)
0.8%
Principia Biopharma Inc. (PRNB)
0.78%
Kura Oncology Inc. (KURA)
0.72%
MeiraGTx Holdings PLC (BFYQFJ)
0.69%
UroGen Pharma Ltd. (URGN)
0.65%
Agenus Inc. (AGEN)
0.58%
Magenta Therapeutics Inc. (MGTA)
0.57%
AC Immune SA (ACIU)
0.57%
Voyager Therapeutics Inc. (VYGR)
0.55%
Viking Therapeutics Inc. (VKTX)
0.55%
ImmunoGen Inc. (IMGN)
0.53%
ChemoCenyx Inc. (CCXI)
0.49%
Progenics Pharmaceuticals Inc. (PGNX)
0.47%
Crinetics Pharmaceuticals Inc. (CRNX)
0.47%
MacroGenics Inc. (MGNX)
0.45%
Rigel Pharmaceuticals Inc. (RIGL)
0.41%
Assembly Biosciences Inc. (ASMB)
0.38%
AMAG Pharmaceuticals Inc. (AMAG)
0.38%
Puma Biotechnology Inc. (PBYI)
0.37%
PDL BioPharma Inc. (PDLI)
0.36%
ProQR Therapeutics NV (PRQR)
0.34%
MediciNova Inc. (MNOV)
0.34%
AnaptysBio Inc. (ANAB)
0.34%
Scholar Rock Holding Corp. (SRRK)
0.33%
Corbus Pharmaceuticals Holdings Inc. (CRBP)
0.31%
Xenon Pharmaceuticals Inc. (XENE)
0.25%
Minerva Neurosciences Inc. (NERV)
0.25%
Albireo Pharma Inc. (ALBO)
0.25%
MannKind Corp. (MNKD)
0.23%
GlycoMimetics Inc. (GLYC)
0.22%
Athersys Inc. (ATHX)
0.22%
Kiniksa Pharmaceuticals Ltd. (KNSA)
0.19%
Concert Pharmaceuticals Inc. (CNCE)
0.17%
Marker Therapeutics Inc. (MRKR)
0.14%
PhaseBio Pharmaceuticals Inc. (PHAS)
0.1%
Acorda Therapeutics Inc. (ACOR)
0.1%
Aduro Biotech Inc. (ADRO)
0.09%
Savara Inc. (SVRA)
0.04%
Cash Equivalent
0.02%
ALPS Medical Breakthroughs ETF (SBIO)
0%
Corium International Inc. (CORI-CVR)
0%

SBIO Technicals

Alpha

-2.04

Beta

1.59

Leverage

Long

Standard Deviation

2.04

SBIO Dividends

Dividend Date

2018-12-20

Latest Dividend

0.784

Annual Dividend

0.78

Annual Dividend Rate

0.78

Annual Dividend Yield

1.92

SBIO Performance

YTD Return

47.09%

1 Year Return

26.85%

3 Year Return

74.49%

5 Year Return

0%

10 Year Return

66.63%

SBIO Related Articles

© 2019 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.